Business Context and Reporting Period
Company: Pavmed Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 11, 2020
Event: Entry into a Material Definitive Agreement for a proposed equity offering.
Key Financial Metrics
This filing details a capital raise rather than operational performance metrics. Key figures include:
- Shares Sold: 5,585,000 shares of common stock.
- Purchase Price: $1.60 per share.
- Gross Proceeds: $8,936,000.
- Estimated Net Proceeds: Approximately $8.3 million (after fees and expenses).
- Placement Agent Fees: 7% of gross proceeds from shares sold to investors introduced by agents (3,710,000 shares).
- Expense Reimbursement Cap: $15,000 for out-of-pocket expenses.
Material Changes
The filing reports the execution of Subscription Agreements with investors and a Placement Agency Agreement with Maxim Group LLC and Lake Street Capital Markets LLC. This represents a material change in the company's capital structure pending the closing of the transaction.
Outlook, Risks, and Unusual Items
- Closing Date: Expected on or about December 15, 2020, subject to customary closing conditions.
- Regulatory Basis: The offering is made pursuant to an existing shelf registration statement on Form S-3 (Registration No. 333-248709), declared effective on September 17, 2020.
- Indemnification: The Company agreed to indemnify Placement Agents against certain liabilities under the Securities Act of 1933.
- Emerging Growth Company: The registrant is classified as an emerging growth company.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected December 15, 2020).
- Confirm the final net proceeds after all transaction expenses are deducted.
- Review the attached Placement Agency Agreement (Exhibit 1.1) and Subscription Agreement (Exhibit 10.1) for specific covenants and representations.
- Check subsequent filings for the final use of proceeds and any changes to the capital structure.